$VTEX

Gomide de Faria Mariano sold $19K of VTEX (indirect holdings)

Gomide de Faria Mariano (Chief Executive Officer) sold 4,808 indirectly-held shares of VTEX (VTEX) at $4.00 on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gomide de Faria Mariano
Published Jun 3, 2026, 10:57 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 11:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

This disclosure updates the record of insider activity but does not introduce a new operational, financial, or legal event for VTEX.

02

Market read

Primarily a sentiment/positioning datapoint; likely limited trading impact absent additional catalysts.

03

What to watch

The article provides only one small sale size and does not indicate whether other insiders are selling/buying around the same window.

Relevance 6/10Novelty 2/10Timing: Filed today; sale occurred on 2026-06-01.

Background

SEC Form 4 reports insider trades by officers/directors/10% owners; 10b5-1 plans are pre-arranged to mitigate timing-based trading concerns.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

CEO Gomide de Faria Mariano sold $19.2K of VTEX shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low near-term impact; any move is likely limited to sentiment/flow rather than a new catalyst.

Evidence & confidence

The filing is an SEC Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which reduces the likelihood of information-driven selling.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst mentioned.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with periods of reduced conviction; traders may watch for follow-on sales or larger transactions.

Key entities

  • VTEX

    Subject of the SEC Form 4 insider transaction; CEO sold 4,808 shares for ~$19.2K under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a